IceCure Medical Ltd
ICCM
$1.17
-$0.0647-5.26%
Weiss Ratings | ICCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | ICCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Good | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | ICCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -0.19 | |||
Price History | ICCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 2.22% | |||
30-Day Total Return | -17.35% | |||
60-Day Total Return | -14.32% | |||
90-Day Total Return | 94.74% | |||
Year to Date Total Return | -5.26% | |||
1-Year Total Return | -6.78% | |||
2-Year Total Return | 3.58% | |||
3-Year Total Return | -48.67% | |||
5-Year Total Return | 796.38% | |||
52-Week High % Change | -25.90% | |||
52-Week Low % Change | 156.25% | |||
Price | ICCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $1.66 | |||
52-Week Low Price | $0.48 | |||
52-Week Low Price (Date) | Oct 08, 2024 | |||
52-Week High Price (Date) | Feb 19, 2025 | |||
Valuation | ICCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 69.58M | |||
Enterprise Value | 62.47M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.14 | |||
Earnings Per Share Growth | -55.50% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 36.61 | |||
Price/Book (Q) | 10.08 | |||
Enterprise Value/Revenue (TTM) | 33.13 | |||
Price | $1.17 | |||
Enterprise Value/EBITDA (TTM) | -8.23 | |||
Enterprise Value/EBIT | -8.06 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | ICCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 56.01M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | ICCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 972 4 623 0333 | |||
Address | -- | |||
Website | www.icecure-medical.com | |||
Country | Israel | |||
Year Founded | 2006 | |||
Profitability | ICCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | ICCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | ICCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | $0.03 | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | -30.28% | |||
Earnings Growth (Q YOY) | -49.55% | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | -21.95% | |||
Balance Sheet | ICCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 7.56M | |||
Cash Per Share (Q) | $0.14 | |||
Total Current Assets (Q) | 10.75M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 6.90M | |||
Current Ratio (Q) | 1.950 | |||
Book Value Per Share (Q) | $0.12 | |||
Total Assets (Q) | 12.58M | |||
Total Current Liabilities (Q) | 5.51M | |||
Total Debt (Q) | 459.00K | |||
Total Liabilities (Q) | 5.68M | |||
Total Common Equity (Q) | 6.90M | |||
Cash Flow | ICCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||